Adverum Biotechnologies, Inc. Names Paul B. Cleveland as CEO
Adverum Biotechnologies, Inc. Reports Second Quarter 2015 Financial Results and Provides Update on AVA-101 Program
Adverum Biotechnologies Awarded as Technology Pioneer by World Economic Forum